hVIVO PLC
LSE:HVO
hVIVO PLC
LSE:HVO
Price:
6.6
GBX
-0.75%
Market Closed
Market Cap:
£45.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
hVIVO PLC
LSE:HVO
|
UK |
Multiples-Based Value
The Multiples-Based Value of one
HVO
stock under the Base Case scenario is
14.79
GBX.
Compared to the current market price of 6.6 GBX,
hVIVO PLC
is
Undervalued by 55%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HVO
Multiples-Based Value
Base Case
14.79
GBX
Undervaluation 55%
Multiples Across Competitors
HVO Competitors Multiples
hVIVO PLC Competitors
hVIVO PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
hVIVO PLC
LSE:HVO
|
45.7m GBP | 0.9 | 8.7 | 3.2 | 4.9 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
965.3B USD | 338 | 4 002.1 | 1 146.8 | 2 208.3 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
178.1B USD | 4 | 26.6 | 18.5 | 24.9 | |
| US |
|
Danaher Corp
NYSE:DHR
|
128.3B USD | 5.2 | 35.5 | 18.2 | 26.4 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.9B CHF | 5.1 | 35.3 | 26.3 | 26.3 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
282.7B CNY | 6.2 | 14.8 | 15.3 | 15.3 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.2B USD | 4.4 | 24.2 | 17.8 | 21 | |
| US |
|
Waters Corp
NYSE:WAT
|
28.4B USD | 9 | 44.1 | 28.5 | 35.8 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
27.8B USD | 1.7 | 20.5 | 11.6 | 17.3 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.1B USD | 6.2 | 28.9 | 21.5 | 23.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
